Advocates For Switching Birth Control Pill Face Social, Risk Obstacles

A women's health advocacy group that hopes to meet with FDA within the next year to explore potentially switching oral contraceptives to OTC may be hard-pressed to find a pharmaceutical company interested in sponsoring such a venture

More from Archive

More from Pink Sheet